Skip to content
value.today

Foundry Therapeutics 1, Inc.

Total raised
$163 M
4 rounds on record
Latest round
$45 M
Jan 2025
First round on record
Jan 2019
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Foundry Therapeutics 1, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2025$45 MNo. 4$10 to $50 million

Foundry Therapeutics 1, Inc.: Raise no. 4, Jan 2025

Investors in this round

18 investors had bought by the notice of Feb 10, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$45 M of $60 M offered; $15 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam A. Gridley · Executive Officer, Director
  • Kristen A. Howells · Executive Officer
  • Anselm A. Tan · Director
  • J.C. A. Lopez · Director
  • Leighton A. Read · Director
  • Mark A. Deem · Director
  • Michael A. Carusi · Director
  • Nicole A. Vitullo · Director
  • Paul A. McCreadie · Director
  • Tiffany A. Le · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Gridley, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 10, 2025. Read the notice at the SEC.

equity, optionsSEC
Sep 2021$87 MNo. 3$50 to $250 million

Foundry Therapeutics 1, Inc.: Raise no. 3, Sep 2021

Investors in this round

22 investors had bought by the notice of Dec 21, 2023: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$87 M of $87 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam A. Gridley · Executive Officer, Director
  • Josh A. Makower · Director
  • Leighton A. Read · Director
  • Mark A. Deem · Director
  • Michael A. Carusi · Director
  • Nicole A. Vitullo · Director
  • Paul A. McCreadie · Director
  • Tak A. Cheung · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Gridley, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 21, 2023. Read the notice at the SEC.

equitySEC
Apr 2020$15 MNo. 2$10 to $50 million

Foundry Therapeutics 1, Inc.: Raise no. 2, Apr 2020

Investors in this round

7 investors had bought by the notice of Jul 8, 2021: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $18 M offered; $3 M still to sell
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam D. Gridley · Executive Officer, Director
  • Josh D. Makower · Director
  • Karun D. Naga · Director
  • Leighton D. Read · Director
  • Mark A. Deem · Director
  • Michael A. Carusi · Director
  • Tak D. Cheung · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Gridley, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 8, 2021. Read the notice at the SEC.

debt, optionsSEC
Jan 2019$16 MNo. 1$10 to $50 million

Foundry Therapeutics 1, Inc.: Raise no. 1, Jan 2019

Investors in this round

14 investors had bought by the notice of Feb 12, 2019: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $29 M offered; $13 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Karun D. Naga · Executive Officer, Director
  • Mark A. Deem · Executive Officer, Director
  • Hanson S. Gifford III · Director
  • Josh D. Makower · Director
  • Leighton D. Read · Director
  • Michael A. Carusi · Director
  • Tak D. Cheung · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Karun D. Naga, President & CEO. Source: SEC Form D, newest notice filed Feb 12, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Foundry Therapeutics 1, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2025).

    SEC Form D · Feb 2025

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Feb 2025

That is all the official record says: Foundry Therapeutics 1, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Foundry Therapeutics 1, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Foundry Therapeutics 1, Inc.
NameRoleNamed in
Adam A. GridleyExecutive officerFeb 2025
Kristen A. HowellsExecutive officerFeb 2025
Adam J. GridleyExecutive officerSep 2021
Adam D. GridleyExecutive officerJul 2021
Karun D. NagaExecutive officerMay 2020
Mark A. DeemExecutive officerFeb 2019
Adam A. GridleyDirectorFeb 2025
Anselm A. TanDirectorFeb 2025
J.C. A. LopezDirectorFeb 2025
Leighton A. ReadDirectorFeb 2025
Mark A. DeemDirectorFeb 2025
Michael A. CarusiDirectorFeb 2025
Nicole A. VitulloDirectorFeb 2025
Paul A. McCreadieDirectorFeb 2025
Tiffany A. LeDirectorFeb 2025
Josh A. MakowerDirectorDec 2023
Tak A. CheungDirectorDec 2023
Adam J. GridleyDirectorSep 2021
Josh J. MakowerDirectorSep 2021
Leighton J. ReadDirectorSep 2021
Nicole J. WalkerDirectorSep 2021
Paul J. McCreadieDirectorSep 2021
Tak J. CheungDirectorSep 2021
Adam D. GridleyDirectorJul 2021
Josh D. MakowerDirectorJul 2021
Karun D. NagaDirectorJul 2021
Leighton D. ReadDirectorJul 2021
Tak D. CheungDirectorJul 2021
Hanson S. Gifford IIIDirectorMay 2020